Patient characteristics
| N | Median age (range) | Median duration of tamoxifen in months (range) | |
|---|---|---|---|
| Benign endometrium | |||
| (I) Tamoxifen | 35 | 57 (45–83) | 27 (5–84) |
| (II) No tamoxifen | 24 | 62 (50–78) | – |
| Endometrial cancer | |||
| (III) Tamoxifen | 15 | 66 (50–85) | 18 (3–90) |
| (IV) No tamoxifen | 51 | 68 (51–89) | – |